Back to search

Article

A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysis

2023-02-09

Abstract excerpt

<h4>Background: </h4> Rupture of unstable coronary atherosclerotic plaque leads to acute ST segment elevation myocardial infarction which is the most critical type of acute coronary syndrome. Dual anti-platelet therapy is one the main treatments and the combination of Aspirin and Clopidogrel is recognized as the standard oral regimen in most cases. Ticagrelor is a new generation of P2Y12 receptor inhibitors, which...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3768bc68-e571-5928-ad9a-94e54663e17d
DOI
10.21203/rs.3.rs-2512875/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysisDOI 10.21203/rs.3.rs-2512875/v1
Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity
Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity
Dual antiplatelet therapy in patients with coronary artery disease after percutaneous coronary intervention with drug-eluting stents: A systematic review and network meta-analysisSemantic proximity
Evaluating the risk-benefit profile of the direct-acting P2Y(12) inhibitor ticagrelor in acute coronary syndromes.Semantic proximity
A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.Semantic proximity
[Impact of CYP2C19 genotypes on antiplatelet therapy among Chinese patients with acute myocardial infarction after percutaneous coronary intervention].Semantic proximity
Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.Semantic proximity
[Who should receive clopidogrel after stroke?].Semantic proximity
Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous designSemantic proximity
Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndrome.Semantic proximity
Efficacy and safety of genotype-guided antiplatelet therapy versus standard treatment in 4,604 patients with CAD after PCI: a meta-analysis of randomized controlled trials.Semantic proximity
Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: A nationwide retrospective cohort studySemantic proximity
Select a neighboring publication to make it the new centre.